ITMI992107A0 - Uso del baclofen nel trattamento dell'astinenza da etanolo - Google Patents

Uso del baclofen nel trattamento dell'astinenza da etanolo

Info

Publication number
ITMI992107A0
ITMI992107A0 IT99MI002107A ITMI992107A ITMI992107A0 IT MI992107 A0 ITMI992107 A0 IT MI992107A0 IT 99MI002107 A IT99MI002107 A IT 99MI002107A IT MI992107 A ITMI992107 A IT MI992107A IT MI992107 A0 ITMI992107 A0 IT MI992107A0
Authority
IT
Italy
Prior art keywords
baclofen
treatment
ethanol withdrawal
withdrawal
ethanol
Prior art date
Application number
IT99MI002107A
Other languages
English (en)
Inventor
Giancarlo Colombo
Gian Luigi Gessa
Giovanni Addolorato
Original Assignee
Neuroscienze S C A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroscienze S C A R L filed Critical Neuroscienze S C A R L
Publication of ITMI992107A0 publication Critical patent/ITMI992107A0/it
Priority to IT1999MI002107A priority Critical patent/IT1319275B1/it
Priority to PCT/EP2000/009750 priority patent/WO2001026638A2/en
Priority to PL354083A priority patent/PL200525B1/pl
Priority to AU79146/00A priority patent/AU7914600A/en
Priority to EP00969423A priority patent/EP1217999B1/en
Priority to ES00969423T priority patent/ES2246900T3/es
Priority to CA002386817A priority patent/CA2386817C/en
Priority to DE60021590T priority patent/DE60021590T2/de
Priority to AT00969423T priority patent/ATE300295T1/de
Priority to DK00969423T priority patent/DK1217999T3/da
Publication of ITMI992107A1 publication Critical patent/ITMI992107A1/it
Priority to HK02109321.9A priority patent/HK1048062A1/zh
Application granted granted Critical
Publication of IT1319275B1 publication Critical patent/IT1319275B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
IT1999MI002107A 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo. IT1319275B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.
CA002386817A CA2386817C (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
PL354083A PL200525B1 (pl) 1999-10-08 2000-10-05 Zastosowanie baklofenu do wytwarzania leku
AU79146/00A AU7914600A (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcohol withdrawal syndrome and to promote alcohol abstinence in alcoholics
EP00969423A EP1217999B1 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
ES00969423T ES2246900T3 (es) 1999-10-08 2000-10-05 Uso de baclofeno en el tratamiento del alcoholismo.
PCT/EP2000/009750 WO2001026638A2 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
DE60021590T DE60021590T2 (de) 1999-10-08 2000-10-05 Verwendung von baclofen zur behandlung von alkoholismus
AT00969423T ATE300295T1 (de) 1999-10-08 2000-10-05 Verwendung von baclofen zur behandlung von alkoholismus
DK00969423T DK1217999T3 (da) 1999-10-08 2000-10-05 Anvendelse af baclofen til behandling af alkoholisme
HK02109321.9A HK1048062A1 (zh) 1999-10-08 2002-12-24 巴氯酚(baclofen)在酒精中毒治療中的應用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.

Publications (3)

Publication Number Publication Date
ITMI992107A0 true ITMI992107A0 (it) 1999-10-08
ITMI992107A1 ITMI992107A1 (it) 2001-04-08
IT1319275B1 IT1319275B1 (it) 2003-09-26

Family

ID=11383744

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.

Country Status (11)

Country Link
EP (1) EP1217999B1 (it)
AT (1) ATE300295T1 (it)
AU (1) AU7914600A (it)
CA (1) CA2386817C (it)
DE (1) DE60021590T2 (it)
DK (1) DK1217999T3 (it)
ES (1) ES2246900T3 (it)
HK (1) HK1048062A1 (it)
IT (1) IT1319275B1 (it)
PL (1) PL200525B1 (it)
WO (1) WO2001026638A2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
PT1660440E (pt) 2003-08-20 2012-05-15 Xenoport Inc Pró-fármacos de aciloxialquilcarbamato, métodos de síntese e utilização
WO2006050472A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
WO2006050471A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US7872046B2 (en) 2008-01-25 2011-01-18 Xenoport, Inc. Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US8062870B2 (en) 2008-01-25 2011-11-22 Xenoport, Inc. Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
WO2010017498A1 (en) 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing n-hydroxysuccinimidyl carbonates
US8299291B2 (en) 2008-08-07 2012-10-30 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
EP2403486A1 (en) 2009-03-03 2012-01-11 XenoPort, Inc. Sustained release oral dosage forms of an r-baclofen prodrug
US8344028B2 (en) 2009-04-17 2013-01-01 Xenoport, Inc. Gamma-amino-butyric acid derivatives as GABAB receptor ligands
DE102010011069A1 (de) 2010-03-11 2011-09-15 Susanne Haamann Verfahren zur gezielten pharmakologischen und co-psychotherapeutischen Behandlung der Alkoholabhängigkeit mit Baclofen und Nalmefen
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
EP3244884A4 (en) * 2015-01-15 2018-07-25 Allaysis, LLC Intravenous baclofen formulations and treatment methods

Also Published As

Publication number Publication date
WO2001026638A2 (en) 2001-04-19
ES2246900T3 (es) 2006-03-01
EP1217999A2 (en) 2002-07-03
PL354083A1 (en) 2003-12-29
IT1319275B1 (it) 2003-09-26
ATE300295T1 (de) 2005-08-15
DE60021590T2 (de) 2006-05-24
WO2001026638A3 (en) 2002-02-28
DE60021590D1 (de) 2005-09-01
HK1048062A1 (zh) 2003-03-21
ITMI992107A1 (it) 2001-04-08
CA2386817C (en) 2009-05-12
PL200525B1 (pl) 2009-01-30
CA2386817A1 (en) 2001-04-19
AU7914600A (en) 2001-04-23
EP1217999B1 (en) 2005-07-27
DK1217999T3 (da) 2005-11-28

Similar Documents

Publication Publication Date Title
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IL150628A0 (en) Use of lipid conjugates in the treatment of disease
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
IL153236A0 (en) The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
NO984572D0 (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
ITRM960396A0 (it) Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
GB0316026D0 (en) Compositions containing gangliosides for use in the treatment of skin disorders
ITMI20001216A0 (it) Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
ITBO980239A0 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
IT9047677A1 (it) Impiego di l-carnitina nel trattamento delle miopatie funzionali laringee.
IT1318263B1 (it) Dispositivo massaggiatore da inserire all'interno dello schienale dipoltrona di massaggio o simili.
GB9910197D0 (en) Multivalent agents for use in the treatment of mitochondrial diseases
IT1318588B1 (it) Uso della nimesulide nel trattamento di patologie dermatologiche.
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
YU40098A (sh) Upotreba olanzapina za dobijanje leka